Related Experiment Video
Updated: Jun 8, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Clinical Features and Outcomes of Pediatric MYH7-Related Dilated Cardiomyopathy
Fernando de Frutos1,2,3,4, Juan Pablo Ochoa1,2,3,4, Gregory Webster5
1Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro IDIPHISA Madrid Spain.
Insights
Pediatric dilated cardiomyopathy (DCM) caused by MYH7 gene variants often begins early in life and has a poor prognosis. Advanced New York Heart Association class and low left ventricular ejection fraction predict heart failure events.
Area of Science:
- Cardiology
- Genetics
- Pediatrics
Background:
- Genetic variants in the MYH7 gene are the most common cause of pediatric genetic dilated cardiomyopathy (DCM).
- Limited studies have described the clinical features and prognosis of pediatric MYH7-related DCM.
- This study aims to characterize clinical presentations, analyze variant locations, and identify prognostic factors in this patient population.
Purpose of the Study:
- To describe the clinical features of pediatric patients with MYH7-related DCM.
- To analyze the location of MYH7 variants.
- To identify predictors of poor prognosis in pediatric MYH7-related DCM.
Main Methods:
- Retrospective analysis of clinical records from 44 pediatric patients (<18 years) with pathogenic/likely pathogenic MYH7 variants diagnosed with DCM.
- Data collected from 13 international centers.
- Risk factors for end-stage heart failure (heart transplantation or heart failure-related death) were explored.
Main Results:
- Fifty percent of patients were diagnosed before 6 months of age, with 16% diagnosed at birth.
- Left ventricular (LV) hypertrabeculation was present in 38% of patients, particularly those with variants in the MYH7 head domain.
- At a median follow-up of 6.1 years, 36% of patients required heart transplantation or died from heart failure. Advanced New York Heart Association class (HR, 7.67) and LV ejection fraction ≤35% (HR, 4.00) were significant predictors of adverse outcomes.
Conclusions:
- Pediatric MYH7-related DCM is characterized by early onset, frequent LV hypertrabeculation, and a generally poor prognosis.
- Advanced New York Heart Association class and low LV ejection fraction are key predictors of end-stage heart failure.
- These findings highlight the need for early diagnosis and intensive management strategies for affected children.
Background:
Although genetic variants in MYH7 are the most frequent cause of pediatric genetic dilated cardiomyopathy (DCM), there are no studies available describing this entity. We sought to describe clinical features, analyze variant location, and explore predictors of bad prognosis in pediatric MYH7-related DCM.
Methods And Results:
We evaluated clinical records from 44 patients (24 men; median age at diagnosis, 0.54 [interquartile range, 0.01-10.8] years) with pathogenic/likely pathogenic variants in MYH7 diagnosed with DCM at pediatric age (<18 years) followed at 13 international centers. We also explored risk factors associated with a composite end point of end-stage heart failure defined as heart transplantation or heart failure-related death. Twenty-two patients (50%) were diagnosed at age <6 months, including 7 (16%) at birth. Left ventricular (LV) hypertrabeculation features were present in 15 (38%), particularly among patients with genetic variants in the head domain. After a median follow-up of 6.1 years (interquartile range, 1.9-13.4), 15 patients (36%) required a heart transplant (n=14) or died due to end-stage heart failure (n=1), 15 patients (36%) persisted with systolic dysfunction despite treatment, 12 (29%) had a significant increase in LV ejection fraction, and 2 were lost to follow-up. Overall, end-stage heart failure event rate was 25% at 5 years. New York Heart Association class III to IV (hazard ratio [HR], 7.67 [95% CI, 2.16-27.2]; P=0.002) and LV ejection fraction ≤35% (HR, 4.00 [95% CI, 1.11-14.4]; P=0.03) were the best predictors of bad prognosis.
Conclusions:
Pediatric MYH7-related DCM is characterized by early onset, frequent LV hypertrabeculation, and poor prognosis. Advanced New York Heart Association class and low LV ejection fraction emerged as predictors of end-stage heart failure.
Related Concept Videos
Myocarditis II: Clinical features and Diagnostic Tests
Mitral Valve Prolapse I: Introduction
Mitral Regurgitation II: Clinical features and Diagnostic Tests
Mitral Valve Prolapse II: Assessment and Management
Pathophysiology of Heart Failure
Myocarditis I: Introduction

